Literature DB >> 28114182

Economic evaluation of an implementation strategy for the management of low back pain in general practice.

Cathrine Elgaard Jensen1, Allan Riis, Karin Dam Petersen, Martin Bach Jensen, Kjeld Møller Pedersen.   

Abstract

In connection with the publication of a clinical practice guideline on the management of low back pain (LBP) in general practice in Denmark, a cluster randomised controlled trial was conducted. In this trial, a multifaceted guideline implementation strategy to improve general practitioners' treatment of patients with LBP was compared with a usual implementation strategy. The aim was to determine whether the multifaceted strategy was cost effective, as compared with the usual implementation strategy. The economic evaluation was conducted as a cost-utility analysis where cost collected from a societal perspective and quality-adjusted life years were used as outcome measures. The analysis was conducted as a within-trial analysis with a 12-month time horizon consistent with the follow-up period of the clinical trial. To adjust for a priori selected covariates, generalised linear models with a gamma family were used to estimate incremental costs and quality-adjusted life years. Furthermore, both deterministic and probabilistic sensitivity analyses were conducted. Results showed that costs associated with primary health care were higher, whereas secondary health care costs were lower for the intervention group when compared with the control group. When adjusting for covariates, the intervention was less costly, and there was no significant difference in effect between the 2 groups. Sensitivity analyses showed that results were sensitive to uncertainty. In conclusion, the multifaceted implementation strategy was cost saving when compared with the usual strategy for implementing LBP clinical practice guidelines in general practice. Furthermore, there was no significant difference in effect, and the estimate was sensitive to uncertainty.

Entities:  

Mesh:

Year:  2017        PMID: 28114182     DOI: 10.1097/j.pain.0000000000000851

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  20 in total

1.  Worsening trends in analgesics recommended for spinal pain in primary care.

Authors:  Stephanie Mathieson; Lisa Valenti; Christopher G Maher; Helena Britt; Qiang Li; Andrew J McLachlan; Chung-Wei Christine Lin
Journal:  Eur Spine J       Date:  2017-06-21       Impact factor: 3.134

2.  Imaging versus no imaging for low back pain: a systematic review, measuring costs, healthcare utilization and absence from work.

Authors:  G P G Lemmers; W van Lankveld; G P Westert; P J van der Wees; J B Staal
Journal:  Eur Spine J       Date:  2019-02-22       Impact factor: 3.134

Review 3.  Scoping review of costs of implementation strategies in community, public health and healthcare settings.

Authors:  Tzeyu L Michaud; Emiliane Pereira; Gwenndolyn Porter; Caitlin Golden; Jennie Hill; Jungyoon Kim; Hongmei Wang; Cindy Schmidt; Paul A Estabrooks
Journal:  BMJ Open       Date:  2022-06-28       Impact factor: 3.006

4.  Luteoloside Inhibits IL-1β-Induced Apoptosis and Catabolism in Nucleus Pulposus Cells and Ameliorates Intervertebral Disk Degeneration.

Authors:  Jialiang Lin; Jiaoxiang Chen; Zengjie Zhang; Tianzhen Xu; Zhenxuan Shao; Xiaobin Wang; Yuanzhe Ding; Naifeng Tian; Haiming Jin; Sunren Sheng; Weiyang Gao; Yan Lin; Xiaolei Zhang; Xiangyang Wang
Journal:  Front Pharmacol       Date:  2019-08-05       Impact factor: 5.810

5.  Effectiveness and cost-utility of a multifaceted eHealth strategy to improve back pain beliefs of patients with non-specific low back pain: a cluster randomised trial.

Authors:  Arnela Suman; Frederieke G Schaafsma; Johanna M van Dongen; Petra J M Elders; Rachelle Buchbinder; Maurits W van Tulder; Johannes R Anema
Journal:  BMJ Open       Date:  2019-12-05       Impact factor: 2.692

6.  How simulation modeling can support the public health response to the opioid crisis in North America: Setting priorities and assessing value.

Authors: 
Journal:  Int J Drug Policy       Date:  2020-04-28

7.  The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics.

Authors:  Zengjie Zhang; Jialiang Lin; Majid Nisar; Tingting Chen; Tianzhen Xu; Gang Zheng; Chenggui Wang; Haiming Jin; Jiaoxiang Chen; Weiyang Gao; Naifeng Tian; Xiangyang Wang; Xiaolei Zhang
Journal:  Oxid Med Cell Longev       Date:  2019-09-09       Impact factor: 6.543

8.  Melatonin protects vertebral endplate chondrocytes against apoptosis and calcification via the Sirt1-autophagy pathway.

Authors:  Zengjie Zhang; Jialiang Lin; Naifeng Tian; Yaosen Wu; Yifei Zhou; Chenggui Wang; Qingqing Wang; Haiming Jin; Tingting Chen; Majid Nisar; Gang Zheng; Tianzhen Xu; Weiyang Gao; Xiaolei Zhang; Xiangyang Wang
Journal:  J Cell Mol Med       Date:  2018-10-24       Impact factor: 5.310

9.  Procyanidin B3 alleviates intervertebral disc degeneration via interaction with the TLR4/MD-2 complex.

Authors:  Ping Shang; Qian Tang; Zhichao Hu; Shiyuan Huang; Yuezheng Hu; Jianhong Zhu; Haixiao Liu
Journal:  J Cell Mol Med       Date:  2020-02-18       Impact factor: 5.310

10.  Costing Methodology and Key Drivers of Health Care Costs Within Economic Analyses in Musculoskeletal Community and Primary Care Services: A Systematic Review of the Literature.

Authors:  Roanna Burgess; James Hall; Annette Bishop; Martyn Lewis; Jonathan Hill
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.